Other study showed that napabucasin, which inhibits STAT3-driven gene transcription, blocks several key molecules in CSC-related signaling pathways, including c-Myc, Nanog and Sox2, in a colon cancer mouse model, thereby suppressing metastases [43]. The gene discussed is STAT3; the disease is colonic neoplasm.